BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1617 related articles for article (PubMed ID: 23934992)

  • 1. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
    Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy.
    Raimondi F; Iserin F; Raisky O; Laux D; Bajolle F; Boudjemline Y; Boddaert N; Bonnet D
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):756-62. PubMed ID: 25711351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
    Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
    Park S; Choi BW; Rim SJ; Shim CY; Ko YG; Kang SM; Ha JW; Jang Y; Chung N; Choe KO; Cho SY
    J Card Fail; 2006 Mar; 12(2):93-9. PubMed ID: 16520255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
    Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.
    Nabeta T; Inomata T; Fujita T; Iida Y; Ikeda Y; Sato T; Ishii S; Maekawa E; Mizutani T; Naruke T; Koitabashi T; Inoue Y; Ako J
    J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Nov; 31(11):1817-1825. PubMed ID: 26843195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.